Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Exelixis, Inc. (EXEL)

« Back to company index

EXEL Chatter Timeline

Stock Ticker for EXEL

Most Active Tweeters for EXEL

UserTweets
@AmericanBanking 9
@prosperousguy 6
@1MinuteStock 6
@TranscriptDaily 5
@slick_trader24 5

Recent Tweets for EXEL

AmericanBanking @AmericanBanking
Exelixis, Inc. $EXEL Expected to Announce Quarterly Sales of $231.61 Million https://t.co/UkvRGDvQiq #stocks
November 10th 2019, 9:11am
BlueBioNow @BlueBioNow
$EXEL significant price movement on this stock 4.09 % change recently https://t.co/eWEVF0GCau
November 9th 2019, 8:11pm
bbnsnews @bbnsnews
Exelixis, Inc. $EXEL Receives $24.71 Consensus Target Price from Brokerages https://t.co/4NZQemSz9p
November 9th 2019, 5:11pm
ConsumerFeed @ConsumerFeed
Exelixis, Inc. $EXEL Receives $24.71 Average Price Target from Brokerages https://t.co/aISfgKXk3v
November 9th 2019, 5:11pm
Gambiste1 @Gambiste1
RT @biotechw2019: $EXEL want to stabilize at gap filled and 3 years support of indecision triangle. a break down here and the target is $12…
November 9th 2019, 1:11pm
prosperousguy @prosperousguy
@semodough Hey Dough, $EXEL Bull here, can you list more of the events/catalysts for $EXEL that are coming up? TIA
November 9th 2019, 12:11pm
prosperousguy @prosperousguy
@rosderek @newsfilterio Any links to upcoming $EXEL events/catalysts? Love to see that TIA
November 9th 2019, 12:11pm
biotechw2019 @biotechw2019
$EXEL want to stabilize at gap filled and 3 years support of indecision triangle. a break down here and the target… https://t.co/cn1Bhcn0AB
November 9th 2019, 11:11am
rosderek @rosderek
@prosperousguy @newsfilterio Appreciate your inputs on $exel, IMO don’t see a BO, especially at $27, mgmt thinks Ca… https://t.co/CSV7NcGnc1
November 9th 2019, 11:11am
prosperousguy @prosperousguy
@newsfilterio I want to be able to say that, THAT sale was the worst ever by a supposed 'insider" as $EXEL pops $11… https://t.co/fltnTIOaL9
November 9th 2019, 11:11am
ThisLincolnian @ThisLincolnian
Exelixis, Inc. $EXEL CMO Gisela Schwab Sells 50,000 Shares https://t.co/8OS7LsV0VN
November 9th 2019, 5:11am
WeekHerald @WeekHerald
Exelixis, Inc. $EXEL CMO Sells $799,500.00 in Stock https://t.co/80r4FZKG3d
November 9th 2019, 4:11am
endpts @endpts
Eyeing second Japanese approval, #Daiichi and Exelixis announce positive pivotal for kidney drug https://t.co/IqS9aZvzEs $EXEL
November 8th 2019, 7:11pm
gcassidy718 @gcassidy718
$EXEL sizable quote changes 2.67 % change recently https://t.co/yJURATPF4w
November 8th 2019, 4:11pm
slick_trader24 @slick_trader24
$EXEL weekly chart https://t.co/sSmuPAFMCQ
November 8th 2019, 2:11pm
Briefingcom @Briefingcom
$EXEL: Exelixis collaborator Daiichi Sankyo reports positive results from Phase 3 pivotal trial of Esaxerenone https://t.co/sJ9Gy3boMJ
November 8th 2019, 8:11am
stocknewstimes @stocknewstimes
Exelixis $EXEL Stock Rating Upgraded by ValuEngine https://t.co/lr4NzP3NWz
November 8th 2019, 8:11am
newsfilterio @newsfilterio
$524,000.00 of shares sold by Schwab Gisela (Pres, Prod Dev & Med Aff & CMO) $EXEL https://t.co/Z5rYoUTw4R
November 8th 2019, 5:11am
AmericanBanking @AmericanBanking
Zacks: Brokerages Expect Exelixis, Inc. $EXEL Will Announce Earnings of $0.15 Per Share https://t.co/8Ch4MCNqIu #stocks
November 8th 2019, 5:11am
OlympiaReport @OlympiaReport
Zacks: Brokerages Expect Exelixis, Inc. $EXEL Will Announce Earnings of $0.15 Per Share https://t.co/Y56LH9tp8v
November 8th 2019, 5:11am
dispatchtribune @dispatchtribune
Zacks: Brokerages Expect Exelixis, Inc. $EXEL Will Announce Earnings of $0.15 Per Share https://t.co/VFaeurwu3Z
November 8th 2019, 5:11am
Gambiste1 @Gambiste1
RT @slick_trader24: $EXEL gap filled and now some good news released tonight
November 7th 2019, 9:11pm
slick_trader24 @slick_trader24
$EXEL gap filled and now some good news released tonight
November 7th 2019, 8:11pm
ZolmaxNews @ZolmaxNews
Exelixis, Inc. $EXEL Receives $24.71 Consensus Target Price from Brokerages https://t.co/IkOGXP84mQ
November 7th 2019, 4:11pm
dispatchtribune @dispatchtribune
Exelixis, Inc. $EXEL CMO Gisela Schwab Sells 50,000 Shares https://t.co/ft3YSauy4w
November 7th 2019, 10:11am
OlympiaReport @OlympiaReport
Exelixis, Inc. $EXEL CMO Sells $799,500.00 in Stock https://t.co/xkpxDhXf0z
November 7th 2019, 10:11am
insiderbuyings @insiderbuyings
$EXEL new insider selling: 50000 shares. https://t.co/xjRrt8STVo
November 6th 2019, 11:11pm
AmericanBanking @AmericanBanking
Insider Selling: Exelixis, Inc. $EXEL CMO Sells 50,000 Shares of Stock https://t.co/ZGV7NfFlTn #stocks
November 6th 2019, 9:11pm
WatchlistN @WatchlistN
Insider Selling: Exelixis, Inc. $EXEL CMO Sells 50,000 Shares of Stock https://t.co/nxSZSlBTNC
November 6th 2019, 9:11pm
TickerReport @TickerReport
Insider Selling: Exelixis, Inc. $EXEL CMO Sells 50,000 Shares of Stock https://t.co/HTfCfPaw14
November 6th 2019, 9:11pm
dailypoliticaln @dailypoliticaln
Gisela Schwab Sells 50,000 Shares of Exelixis, Inc. $EXEL Stock https://t.co/4LyFXT4Ye2
November 6th 2019, 9:11pm
InsiderAlertsIA @InsiderAlertsIA
$EXEL: New Insider Filing on Pres, Prod Dev & Med Aff & CMO GISELA SCHWAB: https://t.co/nsGshDTwou
November 6th 2019, 8:11pm
MonitorAction @MonitorAction
$EXEL Gisela Schwab Dumps 50K Shares of EXELIXIS, INC. https://t.co/pnjfaC4rgT
November 6th 2019, 8:11pm
StockTexts @StockTexts
$EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/ICV7NdCmwl
November 6th 2019, 8:11pm
slick_trader24 @slick_trader24
$EXEL there’s the flush to gap https://t.co/uMTkiw7TEu
November 6th 2019, 4:11pm
dailypoliticaln @dailypoliticaln
Exelixis $EXEL Raised to Sell at ValuEngine https://t.co/rtpGG2qQiQ
November 6th 2019, 8:11am
TranscriptDaily @TranscriptDaily
Q4 2019 Earnings Estimate for Exelixis, Inc. Issued By Oppenheimer $EXEL https://t.co/YRlQpXLMfK
November 6th 2019, 3:11am
stocknewstimes @stocknewstimes
Q4 2019 Earnings Estimate for Exelixis, Inc. Issued By Oppenheimer $EXEL https://t.co/stTchEaZaR
November 6th 2019, 3:11am
OlympiaReport @OlympiaReport
Piper Jaffray Companies Weighs in on Exelixis, Inc.’s Q4 2019 Earnings $EXEL https://t.co/cYeKPPVLb2
November 6th 2019, 3:11am
WeekHerald @WeekHerald
Piper Jaffray Companies Weighs in on Exelixis, Inc.’s Q4 2019 Earnings $EXEL https://t.co/waoICulYfi
November 6th 2019, 3:11am
TickerReport @TickerReport
Exelixis $EXEL Upgraded to Sell by ValuEngine https://t.co/PUy9ENFpgr
November 5th 2019, 10:11pm
ZolmaxNews @ZolmaxNews
Exelixis $EXEL Upgraded to Sell by ValuEngine https://t.co/hn5UdsoSwl
November 5th 2019, 10:11pm
TranscriptDaily @TranscriptDaily
Piper Jaffray Companies Analysts Cut Earnings Estimates for Exelixis, Inc. $EXEL https://t.co/ATGGpAVjwt
November 5th 2019, 3:11am
TheMarketsDaily @TheMarketsDaily
Exelixis, Inc. $EXEL Expected to Post Q4 2019 Earnings of $0.10 Per Share https://t.co/4XFsOV3VFy
November 5th 2019, 3:11am
stocknewstimes @stocknewstimes
Piper Jaffray Companies Analysts Cut Earnings Estimates for Exelixis, Inc. $EXEL https://t.co/1QR2XOBsSf
November 5th 2019, 3:11am
biotechw2019 @biotechw2019
$EXEL appears the weekly support trend line is holding. watching for a follow through week after the support touche… https://t.co/O53iQLdJNS
November 4th 2019, 7:11am
AmericanBanking @AmericanBanking
Exelixis, Inc. $EXEL Receives Consensus Recommendation of “Hold” from Analysts https://t.co/5XIO2PuGTI #stocks
November 4th 2019, 5:11am
TranscriptDaily @TranscriptDaily
Exelixis, Inc. $EXEL Receives Consensus Recommendation of “Hold” from Analysts https://t.co/442Sk2QeNI
November 4th 2019, 5:11am
EnterpriseLeade @EnterpriseLeade
Exelixis, Inc. $EXEL Given Average Rating of “Hold” by Analysts https://t.co/QZELbodMjw
November 4th 2019, 5:11am
AmericanBanking @AmericanBanking
Exelixis, Inc. Forecasted to Earn Q4 2019 Earnings of $0.15 Per Share $EXEL https://t.co/dckKlQAp7C #stocks
November 4th 2019, 3:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.